Hypersensitivity
34 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Immune System Diseases
Narrower: Anaphylaxis 5, Egg Hypersensitivity 2, Food Hypersensitivity 27, Immune Complex Diseases 1, Milk Hypersensitivity 2, Nut Hypersensitivity 2, Peanut Hypersensitivity 17
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| "Rush" regimen for anaphylaxis | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| "Rush" regimen for egg hypersensitivity | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| "Rush" regimen for milk hypersensitivity | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| AR101 for peanut hypersensitivity | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| AR101 powder provided in capsules & sachets for peanut hypersensitivity | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Bezuclastinib for immune complex diseases | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| cow's milk for food hypersensitivity | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| DBFC with 150g of Alpha-gal Knock Out (KO) pork + DBFC with 150g of Wild Type (WT) pork for food hypersensitivity | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Fecal microbiota for peanut hypersensitivity | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| FMXIN002 double dose + FMXIN002 double dose + NAC + FMXIN002 single dose + FMXIN002 single dose + NAC + Epinephrine for anaphylaxis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Food allergy desensitization / Oral Immunotherapy for egg hypersensitivity | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Food allergy desensitization / Oral Immunotherapy for milk hypersensitivity | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Food allergy desensitization / Oral Immunotherapy for peanut hypersensitivity | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| High dose of peanuts for peanut hypersensitivity | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| High dose OIT for peanut hypersensitivity | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| INP20 for peanut hypersensitivity | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Multi-Allergen Oral Immunotherapy + Omalizumab for peanut hypersensitivity | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Nut oral desensitization for nut hypersensitivity | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Omalizumab for anaphylaxis | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Omalizumab for food hypersensitivity | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Omalizumab for peanut hypersensitivity | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Oral immunotheraphy (OIT) for nut hypersensitivity | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Oral immunotheraphy (OIT) for peanut hypersensitivity | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Oral immunotherapy with peanut for peanut hypersensitivity | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Peanut for anaphylaxis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Peanut for peanut hypersensitivity | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 3 |
| Peanut in common foods or supermarket-sourced cow's milk (CM) for peanut hypersensitivity | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Peanut oral immunotherapy for anaphylaxis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Peanut oral immunotherapy for peanut hypersensitivity | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| peanut powder for food hypersensitivity | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Placebo for Multi-Allergen Oral Immunotherapy + Omalizumab for peanut hypersensitivity | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Probiotic for hypersensitivity | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Purified peanut protein extract for peanut hypersensitivity | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 3 |
| Purified peanut protein extract + peanut for peanut hypersensitivity | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.